Kevin J. Black edited misc_sections.md  over 8 years ago

Commit id: 6e00fb79872d357fa36ad2275f3661ae43e4e71a

deletions | additions      

       

# Competing interests  KJB: clinical trials supported by Psyadon Pharmaceuticals, Neurocrine Biosciences, Inc., and Acadia Pharmaceuticals; advisory boards: Auspex (past)  and Acadia; speakers bureau: Acadia. KJB is an (unpaid) member of the F1000Research Advisory Board. Both authors have received research funding from the Tourette Association.  # Grant information  This work was supported in part by the U.S. National Institutes of Health (NIH), grant R21 NS091635, by a research grant from the Tourette Association of America, and by the McDonnell Center for Systems Neuroscience at Washington University.